Heart Failure & Remodeling Flashcards

1
Q

3 etiologies of heart failure

A
  1. Imparied ventricular contractility
  2. Increased afterload
  3. Impaired ventricular relaxation & filling
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Cor Pulmonale

A

Right sided heart failure caused by a primary pulmonary process

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

HFrEF

A

Heart failure with reduced ejection fraction (systolic dysfunction)

Systolic emptying ceases at higher-than-normal ESV; stroke volume falls

Normal venous return is added to increased ESV and so EDV increases as well; this increased pre-load induces a compensatory increase in stroke volume but impaired contractility and reduced EF cause the ESV to remain elevated

Elevated LV pressure is transmitted to the LA via the open mitral valve during diastole and to the pulmonary vein & capillaries resulting in edema

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Causes of HFrEF - 3 categories + examples

A
  1. Direct destruction of heart muscle (MI, myocarditis)
  2. Overstressed heart muscle (Tachycardia)
  3. Volume overload (mitral regurgitation)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

HFnEF

A

Heart failure with normal ejection fraction / diastolic failure

Caused by abnormalities of diastolic relaxation or ventricular filling; ventricular filling occurs at higher pressures; elevated diastolic pressure is transmitted to pulmonary and systemic veins, causing congestion

Ventricle may become hypertrophic in compensation to maintain these higher diastolic pressure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Causes of HFnEF

A
  1. High afterload (HTN, aortic stenosis)
  2. Myocardial thickening / fibrosis (hypertrophic cardiomyopathy)
  3. External compression (pericardial fibrosis/effusion)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Pathological effects of neurohormonal response to heart failure

A
  1. Increased circulating volume may exacerbate congestion
  2. Elevated arteriolar resistance increases afterload
  3. Increased HR exacerbates metabolic demand
  4. Continuous sympathetic activation results in down-regulation of B-adrenergic receptors, decreasing the myocardium’s sensitivity to circulating catecholamines (reduced inotropy)
  5. Chronically elevated AII and aldosterone stimulate fibroblasts, leading to myocardial fibrosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Baroreceptor Reflex

A

BP info is sensed by baroreceptors (stretch-sensitive sensory neurons) in the carotid sinus and aortic arch; these neurons transmit via CN IX to the cardiovascular control center in the medulla; sympathetic outflow from the medulla to the heart is altered

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Production of renin

A

Renin is produced by juxtaglomerular cells in the kidney in response to:

  1. Decreased renal artery perfusion
  2. Direct stimualtion by the adrenergic system
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Actions of angiotensin II

A
  1. Constricts arterioles, raising TPR
  2. Acts on the hypothalamus, stimulating thirst
  3. Acts at adrenal gland to increase aldosterone secretion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Aldosterone

A

Promotes Na+ reabsorption from the kidney

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Anti-Diuretic Hormone (ADH) (Vasopressin)

A

Secreted by the pituitary

Promotes water retention in the distal nephron

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Atrial Natriuretic Peptide (ANP)

A

ANP is stored in atrial cells and released in response to atrial distention; ANP binds at natriuretic peptide receptors (NPRs) whicha re receptor guanylate cyclases that produce cGMP; cGMP activates SERCA to stimulate Ca2+ uptake, thereby reducing cytoplasmic Ca2+ levels, causing:

  1. In the kidneys - Increased GFR and secretion of Na+ and water
  2. In VSMCs - Vasodilation
  3. In the adrenal gland - inhibition of aldosterone and renin release
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Role of hypertrophy in heart failure

A

Heart failure causes chronic elevation of wall stress because of ventricular dilation or the need to generate high systolic pressures in order to overcome excessive afterload

Sustained increase in wall stress stimulates hypertrophy (via LaPlace), which increases wall stiffness and contributes to elevated LV diastolic pressure which are transmitted to the LA, causing pulmonary congestion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Eccentric Hypertrophy

A

Pathological hypertrophy caused by chronic chamber dilation due to volume overload

New sarcomeres are formed in series with the old, causing myocytes to elongate; radius of the ventricular chamber enlarges in proportion to the increase in wall thickness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Concentric Hypertrophy

A

Hypertrophy that often results from physiological mechanisms (i.e. exercise) but can also be pathological

New sarcomeres are synthesized in parallel with the old, causing thickening of myocytes; wall thickness increases without a proportional increase in ventricular radius

17
Q

Orthopnea

A

Sensation of labored breathing while laying flat, relieved by sitting upright; this is a symptom of heart failure related to increased pulmonary congestion

Due to redistribution of intravascular blood from abdomen and lower extremities toward the lungs after laying down

18
Q

Paroxymal Noctural Dyspnea (PND)

A

Severe breathlessness that awakens a patient from sleep after 2-3 hours; this is a symptom of heart failure related to increased pulmonary congestion

Caused by gradual reabsorption of lower extremity interstitial edema into circulation, with subsequent increased venous return to the heart and pulmonary congestion

19
Q

New York Heart Association (NYHA) Functional Classification of Heart Failure

A
  1. Asymptomatic
  2. Symptomatic with moderate exertion
  3. Symptomatic with minor exertion
  4. Symptomatic at rest
20
Q

ACC/AHA Heart Failure Stages

A

A. Patient is at risk of developing heart failure

B. Patient has structural heart disease associated with heart failure but is asymptomatic

C. Patient has current or prior symptoms of heart failure associated with structural heart disease

D. Patient has structural heart disease and market heart failure symptoms despite maximal medical therapy; requires advanced intervention

21
Q

Signs of Left Sided Heart Failure - Low Flow

A

Cool extremities
Dusky appearance
Tachycardia
Low pulse pressure

22
Q

Signs of Left Sided Heart Failure - Increased Left Atrial Pressure

A
Rales 
Rhonchi/wheezing 
Hypoxia
Tachypnea
Orthopnea 
Paroxymal Noctural Dyspnea
23
Q

Rales

A

Created by the “popping open” of small airways during inspiration that had been closed off by the pressure of edema fluid; most prominent at lung bases, where hydrostatic forces are greatest

24
Q

Rhonchi/Wheezing

A

Caused by compression of conduction airways by pulmonary congestion

25
Q

Signs of Right Sided Heart Failure

A

Systemic Edema

Hepatic congestion with RUQ tenderness

Jugular Venous Distension - an estimation of right atrial pressure

S3 Gallop

S4 gallop

26
Q

S3 gallop

A

Caused by rapid expansion of the ventricular walls in early diastole; typical of HFrEF

S1-S2-S3 (Ken-tuc-key)

27
Q

S4 gallop

A

Caused by atria contracting forcefully against a stiff or hypertrophic LV

S4-S1-S2 (Ten-ne-ssee)

28
Q

Upper zone vascular redistribution

A

Evidence of heart failure seen on chest radiograph; vessels supplying the upper lobes of the lungs appear larger than those supplying the lower lobe

Caused by compression of vessels at the lung bases by lung edema secondary to greater hydrostatic pressure

29
Q

BNP

A

Assay for heart failure; BNP levels correlate with degree of LV dysfunction and prognosis with normal BNP < 100

Good negative predictive value - a patient with signs of heart failure but low BNP probably doesn’t have heart failure

30
Q

Implantable Cardioverter-Defibrillator (ICD)

A

Indicated for many patients with chronic ischemic or non-ischemic dilated cardiomyopathies with reduced systolic function

31
Q

Cardiac Resynchronization Therapy (CRT)

A

Bi-ventricular pacemaker for patients with QRS duration > 120 msec (due to L. bundle branch block) and LV ejection fraction < 35%

Causes the LV lateral and septal walls to contract together, producing an efficient contraction and increased SV

32
Q

Role of HDAC9 in cardiomyocyte hypertrophy

A

HDAC9 suppresses hypertrophy in response to stress by deacetylating genes required for hypertrophic growth

Knockout stimulates cardiomyocyte hypertrophy as well as BNP expression; overexpression blocks hypertrophy

33
Q

Role of HDAC 1/2 in cardiomyocyte hypertrophy

A

HDAC1/2 deacetylate genes that suppress growth, thereby allowing the heart to grow in response to stress

HDAC1/2 inhibitors are promising drug candidates for treatment of heart failure

34
Q

Changes in myosin heavy chains seen in cardiac remodeling

A

Pathological hypertension 2/2 chronic hypertension and aortic valve stenosis is characterized by an increase in the B-B MHC isoform and decreased ATPase activity

Physiological hypertrophy due to exercise or pregnancy is characterized by an increase in the A-A MHC isoform and an increase in ATPase activity

35
Q

Role of calcineurin in cardiac remodeling

A

Calcineurin, a Ca2+ dependent phosphatase, targets NFAT; dephosphorylated NFAT move from the cytosol to the nucleus where it acts as a TF for genes related to cardiac remodeling (i.e. B MHC)